| Unrestricted | Funds | EndowmentFunds | Total Funds | |||||
|---|---|---|---|---|---|---|---|---|
| Period 15.07.2021 to | Period 15.07.2021 | Period 15.07.2021 | ||||||
| 31.12.2022 | to31.12.2022 | to31.12.2022 | ||||||
| Note | 8 | 6 | 6 | |||||
| Income and endowments | ||||||||
| from: | ||||||||
| Gift ofexpendable | endowment | 3,017,619 | 3,017,619 | |||||
| Investment income |
52,957 | 52,957 | ||||||
| Other | 206 | 206 | ||||||
| Total income | 53,163 | 3,017,619 | 3,070,782 | |||||
| Expenditure on: | ||||||||
| Cost ofraising funds | 3 | 35,320 | 35,320 | |||||
| Charitable activities |
4,5 | 82,904 | ||||||
| Total expenditure | 82,904 | 35,320 | 118,224 | |||||
| Net income/(expenditure) | before | |||||||
| investment gains/(losses) |
(29„741) | 2,982,299 | 2,952,558 | |||||
| Net gain/(losses) | on Investments | |||||||
| Realised gains/(losses) | on | |||||||
| investments | (28,573) | (28,573) | ||||||
| Unrealised gains/posses) |
||||||||
| on investments | (247,205) | (247,205) | ||||||
| Net income/(expenditure) | (29,741) | 2,706,521 | 2,676,780 | |||||
| Transfers between | funds | 10 | 29,741 | (29,741) | ||||
| Net movement in |
funds | 2,676,780 | 2,676,780 | |||||
| Balance carried forward | ||||||||
| at 31 December 2022 | 2,676,780 | 2,676,780 |
| Unrestricted | Endowment | Total | |||
|---|---|---|---|---|---|
| Fund | Fund | Funds | |||
| 31.12.2022 | 31.12.2022 | 31.12.2022 | |||
| 6 | E | E | |||
| UK equities | 17,376 | 17,376 | |||
| UK fixed interest securities | 4,770 | 4,770 | |||
| UK alternatives | 6,987 | 6,987 | |||
| Overseas equities | 19,094 | 19,094 | |||
| Overseas fixed interest securities | 1,516 | 1,516 | |||
| Interest on | cash deposits | 3,214 | 3,214 | ||
| 52,957 | 52,957 | ||||
| 3. Cost ofraising funds |
|||||
| Unrestricted | Endowment | Total | |||
| Fund | Fund | Funds | |||
| 31.122022 | 31.12.2022 | 31.12.2022 | |||
| E | E | E | |||
| Investment | management | costs | 20,175 | 20,175 | |
| Financial advisor fees | 15,145 | 15,145 | |||
| 35,320 | 35,320 | ||||
| Unrestricted | Endowment | Total | |||
| Fund | Fund | Funds | |||
| 31.12.2022 | 31.12.2022 | 31.12.2022 | |||
| E | E | E | |||
| University scholarships |
72,000 | 72,000 | |||
| 72,000 | 72,000 |
| December 2022 | |||||||
|---|---|---|---|---|---|---|---|
| Expenditure | on charitable | activities | |||||
| Unrestricted | Endowment | Total | |||||
| Fund | Fund | Funds | |||||
| 31.122022f | 31.12.2022 6 |
31.12.2022 6 |
|||||
| Grants (Note 4) | 72,000 | 72,000 | |||||
| Admin and accountancy | 8,250 | 8,250 | |||||
| Bank charges | 30 | 30 | |||||
| Independent Examiner |
2,160 | 2,160 | |||||
| Oflice expense | 464 | 464 | |||||
| 82,904 | 82,904 | ||||||
| 6. Fixed assets |
investments | ||||||
| 31.12.2022 | |||||||
| 6 | |||||||
| Quoted investment | |||||||
| Market value at15 July 2021 | |||||||
| Additions | 3,122,547 | ||||||
| Disposals at opening | market | value | (214,849) | ||||
| Net unrealised gain/goss) |
in the period | (247,205) | |||||
| Market value at31December 2022 | 2,669393 | ||||||
| Historical costat31December 2022 | 2,907,698 | ||||||
| Investments atmarket |
value | Total | |||||
| UK | Overseas | 31.122022 | |||||
| 6 | 6 | 6 | |||||
| Equities | 723,006 | 1,179,377 | 1,902,383 | ||||
| Fixed interest securities | 159,769 | 48,480 | 208,249 | ||||
| Alternatives | 413,773 | 413,773 | |||||
| Cash held within investment | portfolio | 136,088 | 136,088 | ||||
| Total | 1.432,635 | 1,227,857 | 2,660+93 | ||||
| Material investments | |||||||
| 31.12.2022 | |||||||
| 6 | |||||||
| Treasury 7/8% Green Gilt | 52,521 | ||||||
| Astrazeneca Pic |
61,699 | ||||||
| Shell Pic | 74,432 | ||||||
| Ishares VII Pic | 83,250 | ||||||
| Baillie Gifford Jpn Tst | 68,490 | ||||||
| Man Fund Mgmt (UK) | 50,860 | ||||||
| JPMorgan Emerg Mkts | Inv | Tst | 71110 |
| mber 20 | 22 | |||||
|---|---|---|---|---|---|---|
| Liabilities | 31.12.2022 | |||||
| 6 | ||||||
| Amounts | falling | due | within | one | year: | |
| Accruals | 17,611 |
| Unrestricted | Endowment | ||
|---|---|---|---|
| Funds | Funds | Total | |
| 31.12.2022 | 31.12.2022 | 31.12.2022 | |
| Assets | 2,694,391 | 2,694,391 | |
| Liabilities | (17,611) | (17,611) | |
| 2,676,780 | 2,676,780 |